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ABSTRACT Damage to actively transcribed DNA is pref-
erentially repaired by the transcription-coupled repair (TCR)
system. TCR requires RNA polymerase II (Pol II), but the
mechanism by which repair enzymes preferentially recognize
and repair DNA lesions on Pol II-transcribed genes is incom-
pletely understood. Herein we demonstrate that a fraction of
the large subunit of Pol H (Pol II LS) is ubiquitinated after
exposing cells to UV-radiation or cisplatin but not several
other DNA damaging agents. This novel covalent modification
of Pol II LS occurs within 15 min of exposing cells to
UV-radiation and persists for about 8-12 hr. Ubiquitinated
Pol II LS is also phosphorylated on the C-terminal domain.
UV-induced ubiquitination of Pol II LS is deficient in fibro-
blasts from individuals with two forms of Cockayne syndrome
(CS-A and CS-B), a rare disorder in which TCR is disrupted.
UV-induced ubiquitination of Pol II LS can be restored by
introducing cDNA constructs encoding the CSA or CSB genes,
respectively, into CS-A or CS-B fibroblasts. These results
suggest that ubiquitination of Pol II LS plays a role in the
recognition and/or repair of damage to actively transcribed
genes. Alternatively, these findings may reflect a role played
by the CSA and CSB gene products in transcription.
The fidelity of the genetic material must be maintained to
preserve normal cell function and to prevent disruption of
genes that might lead to neoplastic transformation. The cell
has developed several mechanisms for repairing DNA damage
including the versatile nucleotide excision repair (NER) sys-
tem (1). Transcription-coupled repair (TCR), a specialized
form of NER, preferentially corrects damage to the tran-
scribed strand of transcriptionally active DNA (1-4). Cells
isolated from patients with Cockayne syndrome (CS), a rare
autosomal recessive disorder, demonstrate defective TCR
(1-4). Two complementation groups are recognized, CS-A
and CS-B. The CSA and CSB genes have been cloned and the
gene products are believed to play a mechanistic role in TCR
(5, 6).
RNA polymerase II (Pol II), the polymerase that transcribes
nearly all protein encoding genes, is also required for TCR. In
yeast with a temperature-sensitive mutation of the large
subunit of Pol II, TCR does not occur at the nonpermissive
temperature (7, 8). In addition TCR can be blocked by
inhibiting Pol II transcription with a-amanitin, and TCR of
DNA under the transcriptional control of inducible promotors
can be enhanced by pharmacologically stimulating the promo-
tors (9, 10).
There is extensive evidence that transcription and NER are
coordinated cellular events. Transcription factor TFIIH, which
is required for initiation of transcription by Pol II, includes
several proteins essential for NER (1-4). At least one of these
proteins is requiredI for both transcription and NER (11).
When an elongating Pol II complex encounters a DNA lesion,
it appears to stall, back up, and then resume elongating once
the lesion is repaired (2, 12). The stalled Pol II complex,
perhaps assisted by the CSA and CSB gene products, may play
a role in efficiently identifying DNA lesions (1-6).
During transcription the C-terminal domain (CTD) of Pol
II's largest subunit (Pol II LS), a subunit that directly contacts
the DNA template, undergoes characteristic changes in its
phosphorylation state. A 220-kDa form of Pol II LS (Pol IIa)
with a hypophosphorylated CTD preferentially binds most
promotors; Pol Ila shifts to a 240-kDa form (IIo) with a
hyperphosphorylated CTD upon promotor clearance and tran-
script elongation (13). Using H14, a monoclonal antibody that
recognizes Pol IIo and several less phosphorylated forms of
Pol II LS (14), we have shown that UV-radiation and other
DNA damaging agents induce a novel covalent modification of
phosphorylated Pol II LS molecules.
MATERIALS AND METHODS
Cell Culture. HeLa cells were maintained in Roswell Park
Memorial Institute (RPMI) 1640 medium containing 7% fetal
bovine serum (Sigma) and 1% glutamine in a 5% C02/95% air
atmosphere at 37°C. They were grown to near confluence for
experimental analysis. UV-irradiation was at 254 nm using a
germicidal lamp with an incident dose rate of 1 J per m2 per
sec followed by incubation at 37°C for the indicated time
period. Cisplatin treatment (20 ,ug/ml) was for 3 hr at 37°C.
H202 treatment (0.25 or 2.0 mM) was for 1 hr at 37°C. Ionizing
(y) irradiation was administered in a 137Cs irradiator; the dose
was either 600 or 1800 rads (6 or 18 Gray) followed by a 60-min
incubation at 37°C.
The primary fibroblast cell lines (GM 5659C, GM 1856B,
GM2965, GM 671, GM 1098B, and GM 1428) were from the
National Institute of General Medical Sciences Human Ge-
netic Mutant Cell Repository (Camden, NJ) and were grown
in RPMI 1640 medium containing 15% fetal bovine serum and
1% glutamine before being treated as indicated.
The simian virus 40 (SV40)-immortalized normal cell line
(VH10) as well as SV40-immortalized CS-B cell lines (CS1AN
Sv + CSB antisense and CS1AN Sv + CSB sense) were
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maintained as described (5). The SV40-immortalized CS-A
cell lines (CS3BE.S3.G1 + pDR2 and CS3BE.S3.G1 + pDR2-
CSA) were also maintained as described (6).
Immunoblot and Immunoprecipitation Analysis. For im-
munoblot analysis of whole cell extracts (see Figs. 1, 3, and 4),
cells were lysed in SDS/PAGE sample buffer at 95°C, and then
the proteins were subjected to SDS/PAGE in 6% gels, West-
ern immunoblot analysis with anti-Pol II LS (mAb H14), and
visualization by "enhanced chemiluminescence" (Amersham)
as described (14). For immunoblot analysis with rabbit anti-
ubiquitin, the commercially prepared and lyophilized anti-
serum (Sigma) was reconstituted in 10 ml of 3% bovine serum
albumin (Sigma) in Tris-buffered saline (50 mM Tris-HCl, pH
7.4/150mM NaCl) and then stored in aliquots. An aliquot was
diluted 1:20 in 3% bovine serum albumin in Tris-buffered
saline before being used for immunoblot analysis as described
(14). To demonstrate specificity of polyclonal anti-ubiquitin
immunoblot analysis, the procedure was also carried out in the
presence of ubiquitin from bovine red blood cells at 1 mg/ml
(Sigma).
For immunoprecipitation with mAb H14 or monoclonal
anti-ubiquitin (mAb 1510; Zymed), HeLa cells were lysed with
"hot 1% SDS" as described (14). Lysates were incubated with
antibodies coupled to protein G-Sepharose beads (Pharmacia
LKB), washed, eluted with SDS/PAGE sample buffer, and
subjected to SDS/PAGE in 6% gels and immunoblot analysis
with the indicated antibody as described (14).
Transient Transfection with HA-UBI. HeLa cells grown to
50-70% confluence on 150-mm dishes were transfected with
50 ,ug of the cDNA expression construct HA-U131 (15) or
control construct pSF with 0.25 ml of LipofectAmine
(GIBCO/BRL) for 6 hr according to the manufacturers
specifications. After another 24 hr in standard growth medium,
the cells were subjected to UV-irradiation (where indicated).
Cells were lysed with hot SDS buffer then the protein was
immunoprecipitated as described (14). Immunoprecipitated
material was subjected to SDS/PAGE in 6% gels and immu-
noblot analysis with the indicated antibodies as described
above. The antibodies employed were mAb H14, control
antibody H22 (C) (14), and monoclonal anti-HA (12CA5-
Babco, Richmond, CA).
RESULTS
DNA Damaging Agents Induce a Novel Covalent Modifica-
tion of Pol II LS. Immunoblot analysis of untreated HeLa cell
extracts using mAb H14 yielded a broad band formed by
hyperphosphorylated Pol IIo, hypophosphorylated Pol hIa,
and numerous forms with an intermediate level of phosphor-
ylation (Fig. 1A, end lanes). Exposure of the cells to UV-
radiation followed by an 8- to 60-min "recovery" at 37°C led
to the appearance of a Pol II LS species that migrated more
slowly than Pol IIo (Fig. 1A, discrete bands denoted x and x').
A smear of bands that migrated more slowly than x' was also
observed.
Pol IIx, x', and the smear were also recognized by H5,
another highly specific anti-Pol II LS mAb (14), as well as a
polyclonal anti-Pol II LS antibody (results not shown). These
upper molecular mass forms of Pol II LS were induced in all
mammalian repair proficient cells tested including MDCK,
COS, and several normal human fibroblast cell lines. Pol lix,
x', and the smear were also induced by cisplatin (Fig. 1A),
which causes bulky DNA lesions repaired by NER (16), and by
mitomycin C and methyl methanesulfonate (results not
shown). In contrast, ionizing radiation and hydrogen peroxide,
which primarily cause oxidative DNA damage corrected by
other repair mechanisms (17, 18), induced little or no Pol Ilx
and x' (Fig. 1A). Thus, cells exposed to a subset of DNA
damaging agents demonstrated a novel covalent modification
of Pol II LS.
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FIG. 1. DNA damaging agents induce novel slow-migrating forms
of Pol II LS. Western immunoblots with H14, a mAb specific for Pol
II LS, are shown. (A) HeLa cells were either untreated (-) or treated
with UV-radiation, cisplatin, H202, or ionizing irradiation (IR) as
indicated. Cells subjected to UV or ionizing radiation were subse-
quently allowed to recover at 37°C for the indicated period of time.
Cisplatin and H202 were present during the entire incubation so the
(stimulus free) recovery time is denoted NA (not applicable). (B)
Kinetic analysis of Pol ILx and x' induction. HeLa cells were either
untreated (-) or irradiated with a UV pulse (15 J/m2) and then
allowed to recover at 37°C for the indicated period of time. The UV
pulses were timed so that all samples could be processed within a short
time interval thus minimizing differences in cell number.
In an extended time course, the upper molecular mass forms
of Pol II LS appeared within 15 min of the UV pulse, reached
maximal levels by 1-3 hr, and were no longer detectable after
12-16 hr (Fig. IB). The kinetics of this modification are similar
to those of TCR as well as UV-induced transcriptional arrest
in human cells (5, 19).
The Upper Molecular Mass Forms of Pol II LS Induced by
UV Radiation Are Ubiquitinated. When Pol II LS from lysates
of UV-irradiated cells was immunoprecipitated with mAb H14
then subjected to immunoblot analysis, the upper molecular
mass forms were recognized by rabbit anti-ubiquitin antibodies
(Fig. 2A, lane 2). Specific binding of anti-ubiquitin to Pol II LS
was completely blocked by ubiquitin (1 mg/ml) (Fig. 2A, lane
4). In addition, upper molecular mass forms of Pol II LS could
be immunoprecipitated from lysates of UV-irradiated HeLa
cells by a monoclonal anti-ubiquitin antibody (mAb 1510) (Fig.
2B, lanes 2 and 3).
Several eukaryotic proteins contain ubiquitin-like domains
that might cross-react with anti-ubiquitin antibodies. These
include the human homologue of Saccharomyces cerevisiae
RAD23 (20), which is involved in NER, and the 18-kDa
subunit of elongin, which helps Pol II elongation complexes to
transcribe past intragenic pause sites (21). To demonstrate that
the upper molecular mass forms of Pol II LS resulted from
bona fide ubiquitination, we transiently transfected HeLa cells
with HA-UBI, a construct that expresses eight tandem copies
of ubiquitin, each tagged with a hemagglutinin (HA) epitope
(15). HA-tagged ubiquitin was incorporated into Pol lIx in
transfected cells after UV-irradiation followed by incubation
at 37°C for 8 or 60 min, (Fig. 2C, lanes 2 and 3). NoHA epitope
was incorporated into Pol ILx in cells transfected with a control
plasmid pSF (Fig. 2C, lane 6) although such cells showed
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FIG. 2. Pol 11 LS is ubiquitinated in cells exposed to DNA damaging agents. (A) HeLa cells were treated as indicated and extracts were
immunoprecipitated (IP) with anti-Pol II LS (H14) followed by immunoblot analysis with a polyclonal anti-ubiquitin antiserum in the absence (lanes
I and 2) or presence (lanes 3 and 4) of ubiquitin at 1 mg/ml. (B) Extracts of HeLa cells treated as indicated were immunoprecipitated with either
monoclonal anti-ubiquitin or a control antibody (IgG) before being subjected to immunoblot analysis with anti-Pol II LS (H14). (C) HeLa cells
were transfected with HA-UBI, a construct expressing HA-tagged ubiquitin, or pSF, a construct expressing an unrelated polypeptide then exposed
to UV-radiation (+) 24 hr later. Proteins immunoprecipitated by anti-Pol II LS (H14) or control antibody (C) were subjected to immunoblot (IB)
analysis with anti-HA (mAb 12CA5, lanes 1-6) or anti-Pol II LS (H14, lanes 7-12).
normal UV-induction of Pol lIx as demonstrated by immuno-
blot analysis with mAb H14 (Fig. 2C, lane 12).
UV-Induced Ubiquitination of Pol II LS Is Deficient in CS
Cells. If ubiquitination of Pol II LS is induced by DNA
damaging agents, it might be altered in cells with TCR
deficiencies. Fibroblasts from four different CS cell lines
showed absent or drastically reduced induction of Pol lIx and
x' (Fig. 3, lanes 4-9 and 13-18). In contrast, normal fibroblasts
and XP-C fibroblasts deficient in "genome overall" NER (22)
show induction of discrete Pol lIx and x' species (Fig. 3, lanes
1-3 and 10-12). UV-induction of Pol lIx and x' has also been
demonstrated in XP-A, XP-B, and XP-D fibroblasts, as well as
several additional normal fibroblast lines (results not shown).
Although faint smears could be observed in the lanes repre-
senting the UV-treated CS cells (lanes 6, 8, 9, 14, 15, 17, and
18), the discrete Pol lIx and x' bands were markedly dimin-
ished.
Restoration of UV-Induced Ubiquitination of Pol II LS in
CS-A and CS-B Fibroblasts With CSA and CSB cDNA. Im-
mortalized CS-A and CS-B fibroblasts are available that have
been stably transfected with CSA and CSB expression con-
structs, respectively (5, 6). CS-A fibroblasts stably expressing
the CSA expression construct demonstrated full restoration of
UV-induced Pol II LS ubiquitination and CS-B fibroblasts
stably expressing the CSB construct showed restoration of a
substantial amount of UV-induced ubiquitination (Fig. 4).
Thus, UV-induced ubiquitination of Pol II LS appears to
require normal CSA and CSB gene products.
DISCUSSION
DNA damaging agents induce the ubiquitination of Pol II LS.
The ubiquitinated forms of Pol II LS are also phosphor-
ylated on the CTD because they are recognized by H14 and
H5, both of which bind to CTD epitopes in a phosphorylation-
dependent manner (14; E. Kim, L. Du, D.B.B. and S.L.W.,
unpublished data). Elongating Pol II, the form that might
accumulate at intragenic DNA lesions, has a phosphorylated
CTD (13). A transcriptionally inactive fraction of Pol II LS also
has a highly phosphorylated CTD (14).
The prominent Pol II LS species denoted x and x' are likely
to represent large subunits with one and two copies of ubiq-
uitin, respectively. The smear of slower migrating forms that
can be seen in addition to Pol lIx and x' (Figs. 1A and 2A and
B) are probably due to multiubiquitination of Pol II LS. A low
level of ubiquitination was detected in bands migrating at the
position of Pol IIo in samples from unirradiated cells (Fig. 2,
lanes 1). This may represent constitutive ubiquitination of Pol
II or it may represent low-level cross-reactivity of the antibod-
ies with the large amount of Pol IIo that is present (see Fig. 2C,
lane 7). The amount of ubiquitination was clearly increased
after UV-irradiation. Similarly, the weak anti-HA immunore-
active bands migrating at the position of Pol IIo in Fig. 2C,
lanes 5 and 6 (sham transfected), are probably due to nonspe-
cific binding of the anti-HA antibody to the large amount of
Pol II LS immunoprecipitated by H14 (compare Fig. 2C, lanes
5 and 6 to lanes 11 and 12).
Analysis of digitalized scans of the UV-induction data using
the IMAGE program from the National Institutes of Health
revealed that approximately 7-10% of Pol II LS was modified.
Although the UV dose employed for the studies presented in
this report (10-15 J/m2) would be expected to kill approxi-
mately half of the cells, Pol lIx and x' could also be induced
with 2 J/m2 (results not shown), a dose that does not appre-
ciably reduce survival (5, 23).
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FIG. 3. UV-induced ubiquitination of Pol II LS is deficient in CS cells. Normal fibroblasts, CS-A and CS-B fibroblasts deficient in TCR, and
XP-C fibroblasts deficient in "genome overall" NER were subjected to UV-irradiation (+) and allowed to recover at 37°C as indicated. Western
immunoblots probed with anti-Pol II LS (H14) are shown. Pol lIx and x' in lanes 2, 3, 11, and 12 are highlighted with dots.
The fate of the Pol II LS that becomes ubiquitinated after
UV-irradiation has not been determined in the present study.
The major function of ubiquitination is to target proteins for
degradation in multisubunit complexes called proteasomes
(24, 25). Ubiquitin-mediated cleavage of Pol II LS stalled at
sites ofDNA damage could help the NER machinery to rapidly
gain access to lesions located within actively transcribed genes.
In support of this idea, multiubiquitinated substrates are
usually targeted to the proteasome (24). However, we detect
no significant increase in H14-immunoreactive Pol II LS
breakdown products after UV treatment (Fig. 1B). This could
be due to loss of the H14 epitope upon Pol II LS cleavage.
Significantly, several ubiquitinated proteins are not targeted
for proteolysis including histones H2A and H2B, actin, and the
platelet-derived growth factor (PDGF) receptor (24, 26-28).
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The ability of colony-stimulating factor 1 (CSF-1) to induce
ubiquitination and membrane localization of the cytoplasmic
protooncogene c-cbl (29) and the dependence of extracellular
signal-induced IKBa kinase activity upon its ubiquitination
(30) indicate that ubiquitination can sometimes play a signaling
function.
Ubiquitination has already been implicated in DNA repair.
The S. cerevisiae RAD6 protein, which is an enzyme involved
in transferring ubiquitin molecules to their substrates, is re-
quired for certain forms of DNA repair (31). The RAD6
protein may be targeted to DNA damage sites by complex
formation with the RAD18 protein (32). Human homologues
of RAD6 have been cloned (33). In addition, DNA repair
defects were observed when the S. cerevisiae ubiquitin genes
were replaced with a mutated ubiquitin gene that would limit
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FIG. 4. UV-induced ubiquitination of Pol II LS can be restored in CS-A and CS-B fibroblasts with CSA or CSB cDNA, respectively.
TCR-competent (VH10) human fibroblasts, CS-A fibroblasts stably transfected with the expression vector pDR2 (control construct) or with a CSA
expression construct, and CS-B fibroblasts stably transfected with a CSB expression construct in antisense orientation (control construct) or a
properly oriented CSB expression construct were subjected to UV-irradiation (+) and allowed to recover at 37°C as indicated. Western immunoblots
probed with anti-Pol II LS (H14) are shown.
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the patterns of multiubiquitin chains that could form on
multiubiquitinated substrates (34). Although these data im-
plicate ubiquitination in DNA repair, the substrates relevant to
DNA repair have not been identified.
Ubiquitination of Pol II LS stalled at DNA lesions could
alter its attachment to the DNA template so that repair
enzymes can gain easier access to the lesion. Pol II stalled at
a DNA lesion is believed to back up (2, 12), and loss of this
response could help explain the TCR deficiency in CS cells.
Similarly, ubiquitination of histones may alter chromatin struc-
ture by changing histone-DNA interactions (25, 35). Another
possible role of ubiquitination could be to "flag" Pol II
elongation complexes that are stalled at DNA lesions thereby
promoting recruitment of the NER machinery to lesions
encountered by the polymerase (2, 3). Alternatively, ubiquiti-
nation of Pol II LS could signal that transcribed DNA has been
damaged so that the cell cycle and/or other regulatory systems
can respond appropriately.
Ubiquitination of Pol II LS subsequent to UV-irradiation or
cisplatin treatment could be a consequence of transcriptional
arrest rather than activation of the TCR pathway. The depen-
dence of UV-induced Pol II LS ubiquitination upon normal
CSA and CSB gene products could reflect a role the CSA and
CSB proteins may play in transcription. Several characteristics
of these proteins are consistent with such a role. The CSB
sequence includes helicase motifs present in the SWI/SNF
family of proteins, which help regulate transcription by reor-
ganizing nucleosome structure (5, 36); the CSA protein binds
to the 44-kDa subunit of transcription factor TFIIH (6). It has
been proposed that some of the clinical manifestations of CS
could result from a generalized transcriptional defect rather
than a DNA repair deficiency (3, 37).
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